Population-based breast cancer screening in Pavia (northern Italy) in 2016-2018: Key performance indicators and sensitivity estimate.

Q2 Medicine

Acta Biomedica de l''Ateneo Parmense Pub Date : 2023-08-30 DOI:10.23750/abm.v94iS3.14511

Silvia Deandrea, Federica Manzoni, Marina Tanious, Andrea Parrini, Marinella Crema, Pietro Perotti, Simona Dalle Carbonare, Giancarlo Magenes, Ennio Cadum, Lorenza Boschetti, Stefano Marguati, Lorella Cecconami, Anna Odone

{"title":"Population-based breast cancer screening in Pavia (northern Italy) in 2016-2018: Key performance indicators and sensitivity estimate.","authors":"Silvia Deandrea, Federica Manzoni, Marina Tanious, Andrea Parrini, Marinella Crema, Pietro Perotti, Simona Dalle Carbonare, Giancarlo Magenes, Ennio Cadum, Lorenza Boschetti, Stefano Marguati, Lorella Cecconami, Anna Odone","doi":"10.23750/abm.v94iS3.14511","DOIUrl":null,"url":null,"abstract":"Background and aim: This study aims to assess the quality of the population-based breast cancer screening programme in Pavia, northern Italy computing its key performance indicators and estimating its sensitivity for the years 2016-2018.Methods: Invitation and examination coverage, participation rate, recall rate, detection rate and positive predictive values were computed on the basis of data provided yearly to the Italian Ministry of Health. Sensitivity was estimated identifying interval cancers in the local Cancer Registry and computed with the proportional incidence method.Results: In 2016-2018 the adjusted invitation coverage was 90%, and the adjusted participation rate was 62%. Recall rate was 8.4% for first screenings and 3.9% for subsequent ones. The number of screen-detected cases was 268, corresponding to a detection rate of 6.6‰ for first screenings and 4.6‰ for subsequent screenings. The number of interval cancers observed was 110 over the study period; the proportional incidence was 22% for the first interval year and 50% for the second interval. The overall sensitivity of the screening program was 64%.Conclusions: The analysis of performance indicators and sensitivity estimates for the Pavia programme indicates that the programme performance is in line with the quality standards set by the European Union and the Italian reference scientific society (GISMa).","PeriodicalId":35682,"journal":{"name":"Acta Biomedica de l''Ateneo Parmense","volume":"94 S3","pages":"e2023160"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Biomedica de l''Ateneo Parmense","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23750/abm.v94iS3.14511","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background and aim: This study aims to assess the quality of the population-based breast cancer screening programme in Pavia, northern Italy computing its key performance indicators and estimating its sensitivity for the years 2016-2018.

Methods: Invitation and examination coverage, participation rate, recall rate, detection rate and positive predictive values were computed on the basis of data provided yearly to the Italian Ministry of Health. Sensitivity was estimated identifying interval cancers in the local Cancer Registry and computed with the proportional incidence method.

Results: In 2016-2018 the adjusted invitation coverage was 90%, and the adjusted participation rate was 62%. Recall rate was 8.4% for first screenings and 3.9% for subsequent ones. The number of screen-detected cases was 268, corresponding to a detection rate of 6.6‰ for first screenings and 4.6‰ for subsequent screenings. The number of interval cancers observed was 110 over the study period; the proportional incidence was 22% for the first interval year and 50% for the second interval. The overall sensitivity of the screening program was 64%.

Conclusions: The analysis of performance indicators and sensitivity estimates for the Pavia programme indicates that the programme performance is in line with the quality standards set by the European Union and the Italian reference scientific society (GISMa).

查看原文本刊更多论文

2016-2018年帕维亚（意大利北部）基于人群的癌症筛查：关键绩效指标和敏感性估计。

背景和目的：本研究旨在评估意大利北部帕维亚基于人群的癌症筛查计划的质量，计算其关键绩效指标并估计其2016-2018年的敏感性，根据每年向意大利卫生部提供的数据计算检测率和阳性预测值。在当地癌症登记处估计识别区间癌症的敏感性，并用比例发病率法计算。结果：2016-2018年调整后的邀请覆盖率为90%，调整后的参与率为62%。第一次筛查的召回率为8.4%，随后的筛查召回率为3.9%。筛查检测到的病例数为268例，第一次筛查的检出率为6.6‰，随后的筛查为4.6‰。在研究期间，观察到的间隔期癌症数量为110例；第一个间隔年的比例发病率为22%，第二个间隔年为50%。筛查项目的总体敏感性为64%。结论：对帕维亚项目的绩效指标和敏感性估计的分析表明，该项目的绩效符合欧盟和意大利参考科学协会（GISMa）制定的质量标准。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Biomedica de l''Ateneo Parmense Medicine-Medicine (all)

CiteScore

4.30

自引率

0.00%

发文量

期刊介绍： Acta Bio Medica Atenei Parmensis is the official Journal of the Society of Medicine and Natural Sciences of Parma, and it is one of the few Italian Journals to be included in many excellent scientific data banks (i.e. MEDLINE). Acta Bio Medica was founded in 1887 and its founders and collaborators, Clinicians and Surgeons, entered history. Acta Bio Medica Atenei Parmensis publishes Original Articles, Commentaries, Review Articles, Case Reports of experimental and general Medicine. A section is devoted to a Continuous Medical Education programme in order to help primary care Physicians to improve the quality of care.